Newsroom
Stay informed with the latest developments from Magnus Medical. Explore the news and stories that showcase how we are driving meaningful change in patient outcomes and advancing our mission to improve brain health.
Magnus Medical Moves to Protect Intellectual Property Behind Breakthrough SAINT Accelerated Depression Therapy
Magnus Medical Announces First Patient Enrolled at University of Massachusetts in Pivotal DoD-Funded Multisite Study of SAINT for Postpartum Depression
In the news
Magnus Medical Moves to Protect Intellectual Property Behind Breakthrough SAINT Accelerated Depression Therapy
The company holds exclusive rights to issued U.S. patents assigned to Stanford University SAINT is…
CNN 5 Good Things Podcast: She Was Depressed for Decades Until She Tried This (Timestamp: 4:28-7:52)
Magnus Medical Announces First Patient Enrolled at University of Massachusetts in Pivotal DoD-Funded Multisite Study of SAINT for Postpartum Depression
$11.6M Department of Defense-supported pivotal study evaluates rapid, personalized, drug-free neuromodulation therapy for postpartum depression…
Magnus Medical Announces Uninterrupted 2026 Payment Stability for SAINT Neuromodulation in CMS OPPS Final Rule
BURLINGAME, Calif., Dec. 2, 2025 — Magnus Medical, Inc., the company behind SAINT®, the first and…
A clinical trial of a new brain stimulation technology finds it is very effective in treating severe depression
From Headsets to Healing: The Rise of Wearable Brain Tech and Its Impact on Mental Illness and Cognitive Health
Media assets
Press kit
Our press kit provides journalists with company background, official logos, fact sheets, and approved assets related to Magnus Medical and SAINT® Depression Therapy.
Find SAINT® near you
The path to feeling better is here. Find a Verified SAINT Provider near you.
